RecruitingNot ApplicableNCT05930496

Evaluating the Effects of an Exercise Intervention on the Gut Microbiota in Stage II-III Colorectal Cancer Survivors

A Randomized Controlled Trial Testing the Effects of an Exercise Intervention on the Gut Microbiota in Colorectal Cancer Survivors: A Pilot and Feasibility Study


Sponsor

Fred Hutchinson Cancer Center

Enrollment

30 participants

Start Date

Jul 8, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

This trial evaluates the effects a moderate-to-vigorous exercise intervention has on the bacterial make-up of the gastrointestinal tract (gut microbiota) in survivors of stage II-III colorectal cancer (CRC). Data shows that the gut microbiota composition and function may be drivers of CRC. High levels of exercise are associated with improved CRC prognosis and survival. While data suggests that exercise has the potential to influence gut microbiota composition and function, it is not known whether these effects contribute to improved CRC prognosis. This clinical trial evaluates the effects an exercise intervention has on gut microbiota and how these effects relate to CRC progression and patient-reported outcomes.


Eligibility

Min Age: 18 YearsMax Age: 70 Years

Plain Language Summary

Simplified for easier understanding

This study examines whether an 8-week supervised exercise program changes the gut bacteria (microbiome) in people who have completed treatment for stage II–III colorectal cancer, and whether these changes are linked to health outcomes. **You may be eligible if...** - You are between 18 and 70 years old - You have a history of stage II–III colorectal cancer with no evidence of current cancer - It has been 60 days to 3 years since your last cancer treatment - Your BMI is between 18.5 and 30 - You exercise less than 60 minutes of moderate-to-vigorous activity per week - You are a non-smoker (no smoking in the past 30 days) - You are able to attend exercise sessions at the study center **You may NOT be eligible if...** - You have taken antibiotics, antifungals, or antiparasitics in the past 6 months - You have a colostomy or ileostomy - You have inflammatory bowel disease (Crohn's or ulcerative colitis) - You are currently obese (BMI 30 or higher) or underweight (BMI below 18.5) - You are pregnant or planning to become pregnant Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREBiospecimen Collection

Undergo collection of blood samples

OTHERExercise Intervention

Receive exercise intervention

OTHERExercise Intervention

Receive tele-coaching intervention

BEHAVIORALHealth Education

Receive health-related information

OTHERInterview

Ancillary studies

OTHERQuestionnaire Administration

Ancillary studies


Locations(1)

Fred Hutch/University of Washington Cancer Consortium

Seattle, Washington, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05930496


Related Trials